This study was carried out to establish an appropriate condition for the efficient cryopreservation of the mouse pronuclear embryo. In vitro cryopreservation of pronuclear embryos was carried out by slow freezing or vitrification methods and development rate of 2-cell, blastocyst and hatched blastocyst was measured as well as survival rate of the thawed pronuclear embryo. After slow freezing, vitrification and thawing of mouse pronuclear embryos, the survival rate and blastocyst development rate for the vitrification group was 97.3 and 53.4%, respectively, which was significantly higher as compared to the slow freezing group with 88.6 and 23.9%, respectively (p<0.05). Blastocyst developmental rate in each experimental group was significantly higher for 21 h in the post-hCG group at 40.5-57.0% than the 24 h post-hCG group at 40.5% (p<0.05). ICM (Inner cell mass) cell numbers of blastocyst-stage embryos during the different stages of mouse pronuclear embryos, slow freezing and vitrification period in the control and vitrification groups were 22.1±2.7 and 17.0±3.1~22.0±3.2, respectively; hence, the slow freezing group (10.2±2.0) had significantly higher cell numbers than those of the other two groups (p<0.05). Trophoblast (TE) cell number in the control group, 65.8±12.6, was significantly higher than in the slow freezing group, 41.6±11.1 (p<0.05). The total cell numbers in the control group and 21 h post hCG group were 87.9±13.6 and 81.8±14.1, respectively, and were significantly higher than for the slow freezing group (51.8±12.6; p<0.05).
Mouse parthenogenetic embryos have been known to be unable to develop to term and are absorbed from Day 11. However, Nagy et al. (1990 Development 110, 815–821) reported that the aggregated tetraploid with embryonic stem (ES) cell developed to term and survived after birth. Thus, our study investigated the developmental capacity of the aggregated ES cells with mouse parthenogenetic embryos. Oocytes obtained from superovulated female mice (BCF1) were treated with 7% ethanol and 5μgmL−1 cytochalasin B for the production of pathenotes and co-cultured with sperm (1×106mL−1) for production of fertilized embryos. The reporter vector (pNeoEGFP) was introduced into ES cells (129S4/SvJae) by electroporation. At the 8-cell stage, pathenotes or fertilized embryos, from which the zona pellucida was removed, were co-cultured with ES cells for 4 h. The aggregated parthenotes or fertilized embryos with 5∼10 ES cells were cultured to the blastocyst stage, and transferred into the uteri of 2.5-day post-coitum pseudopregnant recipients. In experiment I, 144 parthenogenetic blastocysts were transferred into the uterine horns of 9 pseudopregnant recipients, and 5 recipients became pregnant. At Day 9, all fetuses were observed visible in uteri of pregnant fonder mice. At Days 10–11, many fetuses were observed in the progress of absorption in uteri of pregnant fonder mice, but a few fetuses were still alive. However, pathenogenetic fetuses were not detected alive beyond 11 days. In experiment II, the 171 aggregated fertilized embryos with ES cells were transferred (15–20 blastocysts/recipient) into 10 recipients and successfully produced 5 offspring from a recipient. We found that three newborn were chimeric mice derived from ES cells. In experiment III, the 209 aggregated parthenotes with ES cells failed to produce offspring, but inserted pNeoEGFP gene in ES cells was detected in the parthenogenetic 1 of 7 fetuses at 15-days of post-gestation by polymerase chain reactions. Therefore, this result suggests that the parthenotes show restricted development to fetus stage, but the aggregated parthenotes with ES cells might extend their developmental capacity. In the future, we will characterize the mechanism of this unusual phenomenon to understand the role of ES cells during development of chimeric parthenotes with ES cells.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.